Verified peer comparison
Pro-Dex vs Aytu BioPharma Financial Comparison
Direct answer
Pro-Dex and Aytu BioPharma are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Pro-Dex email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Pro-Dex Revenue
- 66,593,000 USD
- Aytu BioPharma Revenue
- 66,382,000 USD
- Pro-Dex Operating income
- 10,689,000 USD
- Aytu BioPharma Operating income
- -7,827,000 USD